Journals / Veteriner Cerrahi Dergisi / 2006 / Cilt: 12 - Sayı: 1

Deneysel osteokondral defekt oluşturulan köpeklerde (Hylan G-F 20) nin kemik metabolizmasına etkisi

The effect of (Hylan G-F 20) on bone metabolism in dogs with experimental osteochondral defects

Pages
20–23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results of study show that Hylan G-F 20 applications could be considered an alternative treatment procedure for osteochondral defects in dogs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to determine the effects of intra-articular Synvisc® (Hylan G-F 20) on bone metabolism in dogs with experimental osteochondral defects.
📊
Key Findings & Data:To defect of 4 mm in diameter and 4 mm in depth, was made in the articular surface of the lateral condyle of 6 dogs by drilling.
💡
Conclusion & Impact:The results of study show that Hylan G-F 20 applications could be considered an alternative treatment procedure for osteochondral defects in dogs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to determine the effects of intra-articular Synvisc® (Hylan G-F 20) on bone metabolism in dogs with experimental osteochondral defects. Deoxypyridinoline (Dpd) and osteocalcin (OC), which have been used as a diagnostic and prognostic marker for joint disease were measured in urine, sera and synovial fluids (SF) from dogs with experimental osteochondral defects. The left stifle joint was used as the for experimental joint. To defect of 4 mm in diameter and 4 mm in depth, was made in the articular surface of the lateral condyle of 6 dogs by drilling. The dogs were given intraarticular SYNVISC® on two occacions, a week apart. No significant differences in sera and SF osteocalcin were found in either groups before and after operation. However, there was a significant difference in the deoxypyridinoline/creatinine ratio between normal and experimental osteochondral defects urine. This may be useful in the monitoring of therapy and prognosis in dogs with osteochondral defects. The results of study show that Hylan G-F 20 applications could be considered an alternative treatment procedure for osteochondral defects in dogs.

Özet

Bu çalısmada, deneysel osteokondral defekt olusturulan köpeklerde intraartiküler Synvisc® (Hylan G-F 20) uygulamasının kemik metabolizmasına etkisini amaçlanmıstır. Eklem hastalıklarının teshis ve prognozunda önemli parametre olarak kabul edilen deoksipiridinoline (Dpd) idrarda ve osteokalsin (OC) serum ve sinovyal sıvıda ölçüldü. Osteokondral defekt deneysel olarak sol articulatio genuda olusturuldu. Köpeklerde femurun lateral kondüluslarına matkap yardımı ile 4 mm çapında ve 4 mm derinliginde defektler olusturuldu. Köpeklere, Synvisc® (Hylan G-F 20) eklem içine bir hafta ara ile iki defa uygulandı. Serum ve sinovyal sıvıdaki osteokalsin degerleri operasyon öncesi ve sonrasında istatistiki farklılıklar göstermedi. Fakat, saglıklı grup ile deneysel osteokondral defekt olusturulan grupdaki deoksipiridinoline/ kreatinin degerlerinde istatistiki farklılıklar bulundu. Deoksipiridinoline/kreatinin degerleri, köpeklerdeki osteokondral defektlerin sagaltımında ve hastalıgın prognozunun takibinde yararlı parametre olarak kabul edilecegi kanısına varıldı. Sonuç olarak Hylan G-F 20, köpeklerdeki osteokondral defektlerin sagaltımında alternatif yöntemi olarak önerilebilir.

🔖

Cite This Article

ARICAN, M., KÖYLÜ, Ö., UYAROĞLU, A., EROL, M., ÇALIM, K. N. (2006). Deneysel osteokondral defekt oluşturulan köpeklerde (Hylan G-F 20) nin kemik metabolizmasına etkisi. Veteriner Cerrahi Dergisi, Cilt: 12 - Sayı: 1, 20–23. https://ajindex.com/articles/333068

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Allen, M.J., L.C. Allen, W.E. Hoffmann., D.C. Richardson and G.J. Breur (2000): Urinary markers of type I collagen degradation in the dog. Research in Veterinary Science 69, 123-127
  2. Arıcan, M., S.D. Carter, D. Bennett and C. May (1994a): Measurement of glycosaminoglycans and keratan sulphate in canine arthropathies. Research in Veterinary Science 56, 290-297
  3. Arıcan, M., S.D. Carter, C. May and D. Bennett (1994b): Hyaluronan in canine arthropathies. Journal of Comparative Pathology 111, 185-195
  4. Arıcan, M., S.D. Carter and D. Bennett (1996): Osteocalcin in canine joint diseases. British Veterinary Journal 152, 1-12
  5. Arıcan, M. (1995): Bone and cartilage metabolism in canine arthropathies. PhD thesis Liverpool
  6. Bennett, D. (1980): The naturally Occurring Inflammatory arthropathies of the dog. PhD thesis, University of Glasgow
  7. Black A., P.A. Schoknecht, S.L. Ralston and S.A Shapses (1999): Diurnal variation and age differences in the biochemical markers of bone turnover in horses. Journal of Animal Science 77, 75-83
  8. Campion, G.V., P.D. Delmas and P.A. Dieppe (1989): Serum and synovial fluid osteocalcin (Bone glaprotein) levels in joint disease. British Journal of Rheumatology 28, 393-398
  9. Eastell, R., A. Colwell, L. Hampton and J. Reeve, (1997): Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. Journal of Bone Mineral Research 12, 59-65
  10. Ekenstram, E.A., S. Ljunghall and R. Hallgren (1986): Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs. Annals of Rheumatic Dieases 45, 484-490
  11. Espallarques, M and J.M. Pons (2003): Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. International Journal of Technology Assess Health Care 19, 41-56
  12. Eyre, D.R., T.J. Koob, and K.P. Vanness, (1984): Quantification of hydroxypyridinium crossslinks in collagen by high performance liquid chromatography. Analytic Biochemical Journal 137, 380-388
  13. Jaffe, P., J.G. Heaf and L. Hyldstrup (1994): Osteocalcin: a non invasive index of metabolic bone disease in patients treated by CAPD. Kidney International Journal 46,838-846
  14. Karlsson, J., L.S. Sjogren and L.S. Lohmander (2002): Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthri